Mesoblast Limited American Depositary Shares (MESO)
Price trend score is near the bottom of its range — how it compares with the broader market is one of its lowest-scoring factors.
MESO scores higher than 29% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, Mesoblast Limited American Depositary Shares (MESO) scores 29 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.84× 30-day average
- 52-week range
- 13.05 – 21.50
- Market cap
- $2.67B
- Earnings date
- —
- Volume
- 178,169
- Avg. volume (30d)
- 211,109
- Open
- 13.93
- Previous close
- 13.75
- Day's range (regular session)
- 13.93 – 14.38
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
What the score says about MESO right now
Mesoblast Limited American Depositary Shares (MESO) currently scores 29/100 on the Market Census six-factor composite, at the Below average score level. MESO is +3.93% on the day and +1.24% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of MESO's data reads poorly than well. The level is a "look before you act" flag. It is not advice. MESO's strongest factor is market mood at 50/100 — a fairly good read on the overall market. The market mood is the same for every ticker at a given moment, so it says nothing about MESO itself. The weakest factor is price trend at 12/100 — a well below average technical read. If the rest of the picture is good, a soft price trend often reflects a re-test of support rather than structural breakdown — descriptively, not as a call to act.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See MESO in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent MESO news
Latest headlines that name Mesoblast Limited American, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil ProductYahoo
- Mesoblast Receives FDA Approval To Implement A New Potency Assay, T-Cell Proliferation Inhibition Bioassay, For Release And Stability Monitoring Of All New Commercial Product Lots Of Its Mesenchymal Stromal Cell Product RyoncilBenzinga
- Mesoblast Reports Substantial Revenue Growth to US$120MGlobeNewswire Inc.
- Mesoblast Reports Ryoncil® Net Revenues of US$36M for the Quarter and US$115M for First Full Year of Product LaunchGlobeNewswire Inc.
- Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back PainGlobeNewswire Inc.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to MESO’s 29, all within 1 point.
Sorted by closeness to MESO’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.